Evaluation of Salmonella enterica Serovar Typhimurium TTSS-2 Deficient fur Mutant as Safe Live-Attenuated Vaccine Candidate for Immunocompromised Mice

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Vishwakarma, Vikalp ^a   Pati, Niladri Bhusan ^a   Chandel, Himanshu Singh ^b   Sahoo, Sushree Sangeeta ^a   Saha, Bhaskar ^b   Suar, Mrutyunjay ^a  

^a KIIT UNIVERSITY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; O ANTIGEN; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL LOAD; BACTERIAL SHEDDING; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; DRUG EFFICACY; FERRIC UPTAKE REGULATOR GENE; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; MICROBIAL ATTENUATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENICITY ISLAND; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; IMMUNIZATION; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTESTINES; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; T-LYMPHOCYTES; VACCINES, ATTENUATED;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 84871328517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052043     Document Type: Article

References (53)

1. Karasova D, Sebkova A, Vrbas V, Havlickova H, Sisak F, et al. (2009) Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential. Vaccine 27: 5265-5270.
2. Hansen-Wester I, Hensel M, (2001) Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect 3: 549-559.
3. Husseiny MI, Hensel M, (2005) Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains. Infect Immun 73: 1598-1605.
4. Hegazy WA, Hensel M, (2012) Salmonella enterica as a vaccine carrier. Future Microbiol 7: 111-127.
5. Germanier R, Fuer E, (1975) Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 131: 553-558.
6. Levine MM, (2010) Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol 8: 129-138.
7. Abd El Ghany M, Jansen A, Clare S, Hall L, Pickard D, et al. (2007) Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines. Infect Immun 75: 1835-1842.
8. Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, et al. (2007) Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Clin Vaccine Immunol 14: 1285-1295.
9. Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, et al. (2009) SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria. Vaccine 27: 2804-2811.
10. Gunn BM, Wanda SY, Burshell D, Wang C, Curtiss R 3rd (2010) Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clin Vaccine Immunol 17: 354-362.
11. Konjufca V, Wanda SY, Jenkins MC, Curtiss R 3rd (2006) A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect Immun 74: 6785-6796.
12. Rychlik I, Karasova D, Sebkova A, Volf J, Sisak F, et al. (2009) Virulence potential of five major pathogenicity islands (SPI-1 to SPI-5) of Salmonella enterica serovar Enteritidis for chickens. BMC Microbiol 9: 268-276.
13. Endt K, Maier L, Kappeli R, Barthel M, Misselwitz B, et al. (2012) Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. Antimicrob Agents Chemother 56: 2295-2304.
14. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, et al. (2010) The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 6(9): e1001097.
15. Hall HK, Foster JW, (1996) The role of fur in the acid tolerance response of Salmonella typhimurium is physiologically and genetically separable from its role in iron acquisition. J Bacteriol 178: 5683-5691.
16. Teixido L, Carrasco B, Alonso JC, Barbe J, Campoy S, (2011) Fur activates the expression of Salmonella enterica pathogenicity island 1 by directly interacting with the hilD operator in vivo and in vitro. PLoS One 6(5): e19711.
17. Troxell B, Sikes ML, Fink RC, Vazquez-Torres A, Jones-Carson J, et al. (2011) Fur negatively regulates hns and is required for the expression of HilA and virulence in Salmonella enterica serovar Typhimurium. J Bacteriol 193: 497-505.
18. Bjarnason J, Southward CM, Surette MG, (2003) Genomic profiling of iron-responsive genes in Salmonella enterica serovar typhimurium by high-throughput screening of a random promoter library. J Bacteriol 185: 4973-4982.
19. Troxell B, Fink RC, Porwollik S, McClelland M, Hassan HM, (2011) The Fur regulon in anaerobically grown Salmonella enterica sv. Typhimurium: identification of new Fur targets. BMC Microbiol 11: 236-254.
20. Yoo AY, Kim SW, Yu JE, Kim YH, Cha J, et al. (2007) Requirement of Fur for the full induction of Dps expression in Salmonella enterica serovar typhimurium. J Microbiol Biotechnol 17: 1452-1459.
21. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645.
22. Lesic B, Rahme LG, (2008) Use of the lambda Red recombinase system to rapidly generate mutants in Pseudomonas aeruginosa. BMC Mol Biol 9: 20-28.
23. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858.
24. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Muller AJ, et al. (2005) The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 174: 1675-1685.
25. Suar M, Periaswamy B, Songhet P, Misselwitz B, Muller A, et al. (2009) Accelerated type III secretion system 2-dependent enteropathogenesis by a Salmonella enterica serovar enteritidis PT4/6 strain. Infect Immun 77: 3569-3577.
26. Vishwakarma V, Periaswamy B, Bhusan Pati N, Slack E, Hardt WD, et al. (2012) A Novel Phage Element of Salmonella enterica Serovar Enteritidis P125109 Contributes to Accelerated Type III Secretion System 2-Dependent Early Inflammation Kinetics in a Mouse Colitis Model. Infect Immun 80: 3236-3246.
27. Roux CM, Butler BP, Chau JY, Paixao TA, Cheung KW, et al. (2010) Both hemolytic anemia and malaria parasite-specific factors increase susceptibility to Nontyphoidal Salmonella enterica serovar typhimurium infection in mice. Infect Immun 78: 1520-1527.
28. Mtove G, Amos B, von Seidlein L, Hendriksen I, Mwambuli A, et al. (2010) Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies. PLoS One 5: e9244.
29. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352: 39-47.
30. Nadjm B, Amos B, Mtove G, Ostermann J, Chonya S, et al. (2010) WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study. BMJ 340: c1350.
31. Suar M, Jantsch J, Hapfelmeier S, Kremer M, Stallmach T, et al. (2006) Virulence of broad- and narrow-host-range Salmonella enterica serovars in the streptomycin-pretreated mouse model. Infect Immun 74: 632-644.
32. Negi VD, Singhamahapatra S, Chakravortty D, (2007) Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model. Vaccine 25: 5315-5323.
33. Chuttani CS, Prakash K, Vergese A, Gupta P, Chawla RK, et al. (1973) Ineffectiveness of an oral killed typhoid vaccine in a field trial. Bull World Health Organ 48: 754-755.
34. Roland KL, Tinge SA, Killeen KP, Kochi SK, (2005) Recent advances in the development of live, attenuated bacterial vectors. Curr Opin Mol Ther 7: 62-72.
35. Spreng S, Dietrich G, Weidinger G, (2006) Rational design of Salmonella-based vaccination strategies. Methods 38: 133-143.
36. Garmory HS, Brown KA, Titball RW, (2002) Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev 26: 339-353.
37. Miller SI, Mekalanos JJ, Pulkkinen WS, (1990) Salmonella vaccines with mutations in the phoP virulence regulon. Res Microbiol 141: 817-821.
38. Fierer J, Okamoto S, Banerjee A, Guiney DG (2012) Diarrhea and Colitis in Mice Require the Salmonella Pathogenicity Island-2 Encoded Secretion Function but not SifA or Spv Effectors. Infect Immun. doi: 10.1128/IAI.00404-12.
39. Ku YW, McDonough SP, Palaniappan RU, Chang CF, Chang YF, (2005) Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis. Infect Immun 73: 8194-8203.
40. Ellermeier JR, Slauch JM, (2008) Fur regulates expression of the Salmonella pathogenicity island 1 type III secretion system through HilD. J Bacteriol 190: 476-486.
41. Tsolis RM, Baumler AJ, Stojiljkovic I, Heffron F, (1995) Fur regulon of Salmonella typhimurium: identification of new iron-regulated genes. J Bacteriol 177: 4628-4637.
42. Johnson M, Sengupta M, Purves J, Tarrant E, Williams PH, et al. (2011) Fur is required for the activation of virulence gene expression through the induction of the sae regulatory system in Staphylococcus aureus. Int J Med Microbiol 301: 44-52.
43. Campoy S, Jara M, Busquets N, de Rozas AM, Badiola I, et al. (2002) Intracellular cyclic AMP concentration is decreased in Salmonella typhimurium fur mutants. Microbiology 148: 1039-1048.
44. Li Y, Wang S, Scarpellini G, Gunn B, Xin W, et al. (2009) Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci U S A 106: 593-598.
45. Santander J, Golden G, Wanda SY, Curtiss R 3rd (2012) Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host. Infect Immun 80: 2689-2703.
46. Johanns TM, Ertelt JM, Rowe JH, Way SS, (2010) Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 6(8): e1001043.
47. Yrlid U, Svensson M, Hakansson A, Chambers BJ, Ljunggren HG, et al. (2001) In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun 69: 5726-5735.
48. McSorley SJ, Asch S, Costalonga M, Reinhardt RL, Jenkins MK, (2002) Tracking Salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 16: 365-377.
49. Gautreaux MD, Deitch EA, Berg RD, (1994) T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun 62: 2874-2884.
50. Dougan G, John V, Palmer S, Mastroeni P, (2011) Immunity to salmonellosis. Immunol Rev 240: 196-210.
51. Apter FM, Michetti P, Winner LS 3rd, Mack JA, Mekalanos JJ, et al (1993) Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun 61: 5279-5285.
52. Hutchings AB, Helander A, Silvey KJ, Chandran K, Lucas WT, et al. (2004) Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J Virol 78: 947-957.
53. Eisenstein TK, Killar LM, Sultzer BM, (1984) Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J Infect Dis 150: 425-435.